Bristol-Myers Squibb BMY Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $7.06B+178% | -$9.01B-212% | $8.04B+26.7% | $6.35B-9.5% | ||
| $4.01B-58.2% | $9.6B-1.6% | $9.76B-5.0% | $10.28B-3.8% | ||
| $553M+9.1% | $507M-2.1% | $518M+13.3% | $457M-21.6% | ||
| $14.16B-6.8% | $15.19B+9.6% | $13.86B+6.1% | $13.07B-19.4% | ||
| $1.31B+5.0% | $1.25B+3.2% | $1.21B+8.1% | $1.12B+14.9% | ||
| $3.94B-81.9% | $21.82B+1,767% | $1.17B-72.7% | $4.29B+166% | ||
| -$4.13B+80.6% | -$21.35B-830% | -$2.3B— | —— | ||
| $5.05B+3.7% | $4.86B+2.5% | $4.74B+2.4% | $4.63B+5.4% | ||
| $10.94B+281% | $2.87B-25.9% | $3.88B-66.1% | $11.43B+89.8% | ||
| -$10.35B— | —— | —— | -$16.96B-4.5% | ||
| -$129M— | —— | $2.19B— | —— | ||
| $12.85B-7.9% | $13.94B+10.2% | $12.65B+5.9% | $11.95B-21.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bristol-Myers Squibb generate?
- Bristol-Myers Squibb (BMY) generated $13.3B in operating cash flow over the trailing twelve months.
- What is Bristol-Myers Squibb's free cash flow?
- After $1.4B of capital expenditures, Bristol-Myers Squibb's free cash flow was $11.9B over the trailing twelve months, down 9.0% year over year.
- Where does Bristol-Myers Squibb's cash flow data come from?
- Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
